Estrella Immunopharma Inc
NASDAQ:ESLA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
E
|
Estrella Immunopharma Inc
NASDAQ:ESLA
|
US |
|
Odawara Engineering Co Ltd
TSE:6149
|
JP |
Bankruptcy Probability
Estrella Immunopharma Inc's probability of bankruptcy is 4.6%, pointing to a small but noticeable default risk. The solvency score is 35/100 — a warning sign of potential financial weakness.
We take all the information about a company's solvency (such as how easily a company can pay interest on its outstanding debt, how much cash it has, the amount of debt, and more) and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Estrella Immunopharma Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
E
|
Estrella Immunopharma Inc
NASDAQ:ESLA
|
43.3m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
G
|
GE Vernova LLC
NYSE:GEV
|
220.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
E
|
Eight Capital Partners PLC
F:ECS
|
158.4B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
C
|
China Industrial Group Inc
OTC:CIND
|
121B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
N
|
Nepi Rockcastle NV
JSE:NRP
|
97B ZAR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Schlumberger NV
NYSE:SLB
|
77.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
F
|
Fintech Ecosystem Development Corp
NASDAQ:FEXD
|
64.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
B
|
Baker Hughes Co
NASDAQ:BKR
|
59.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
G
|
Galderma Group AG
SIX:GALD
|
35.1B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
I
|
Inspire Veterinary Partners Inc
NASDAQ:IVP
|
35.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
C
|
CoreWeave Inc
NASDAQ:CRWV
|
34.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Estrella Immunopharma Inc's probability of bankruptcy is 4.6%, pointing to a small but noticeable default risk.
The probability of bankruptcy is estimated using credit risk models that assess its financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Estrella Immunopharma Inc has no debt.
You can find a full breakdown on its Balance Sheet.
